RxDoctor Payments DataLook up a doctor →

Katie McDaniel, PA

Physician Assistant · Oxford, MSNPI 1356808422

Payments from drug & device makers

$10,240in general payments, 2019–2025

Across 577 payments — averaging $17.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Sun Pharmaceutical Industries Inc.$1K
  • UCB, Inc.$837
  • Johnson & Johnson$813
  • Novartis$632
  • Pfizer$627
  • plus $4K from 22 others

What the payments were for

  • Food & beverage$9,64594%
  • Education$5956%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,240 in reported general payments places this provider in the 95th percentile of 278 physician assistant providers in Mississippi.

See all physician assistant providers in Mississippi

Medicare billing

Part B allowed, 2024
$289,526
Medicare patients
786
Services billed
5,282

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Skyrizi PenRisankizumab-Rzaa14$286,002
Dupixent PenDupilumab68$248,336
Xeljanz XrTofacitinib Citrate11$59,406
Clobetasol Propionate84$3,490
Fluorouracil39$2,738
Betamethasone Dipropionate26$1,276
Ketoconazole66$1,065
Triamcinolone Acetonide63$810
Imiquimod26$635
Metronidazole11$472
Mupirocin36$354
Doxycycline Hyclate29$348
Nystatin11$171

Paid to pharmacies, not to this prescriber.

Other physician assistant in Oxford

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →